New product: Nustendi (bempedoic acid/ezetimibe) 180mg/10mg film-coated tablets
Nustendi is licensed for treatment of adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet, either as monotherapy or in combination with a statin.
Source:
electronic Medicines compendium
SPS commentary:
Bempedoic acid lowers low-density lipoprotein cholesterol by inhibiting cholesterol synthesis in the liver.